163 related articles for article (PubMed ID: 30686546)
1. Altered naive CD4
Kohler S; Keil T; Alexander T; Thiel A; Swierzy M; Ismail M; Rückert JC; Meisel A
J Neuroimmunol; 2019 Feb; 327():10-14. PubMed ID: 30686546
[TBL] [Abstract][Full Text] [Related]
2. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N
Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312
[TBL] [Abstract][Full Text] [Related]
3. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
4. LncRNA XLOC_003810 promotes T cell activation and inhibits PD-1/PD-L1 expression in patients with myasthenia gravis-related thymoma.
Hu B; Niu L; Jiang Z; Xu S; Hu Y; Cao K
Scand J Immunol; 2020 Jul; 92(1):e12886. PubMed ID: 32243615
[TBL] [Abstract][Full Text] [Related]
5. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
Luther C; Poeschel S; Varga M; Melms A; Tolosa E
J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
[TBL] [Abstract][Full Text] [Related]
6. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
7. Thymus, thymoma and myasthenia gravis.
Fujii Y
Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
[TBL] [Abstract][Full Text] [Related]
8. Late onset immunodeficiency in a patient with recurrent thymic carcinoma and myasthenia gravis.
Schmidt S; Padberg F
J Neurol Sci; 1998 May; 157(2):201-5. PubMed ID: 9619646
[TBL] [Abstract][Full Text] [Related]
9. Metaplastic thymoma with myasthenia gravis presumably caused by an accumulation of intratumoral immature T cells: a case report.
Tajima S; Yanagiya M; Sato M; Nakajima J; Fukayama M
Int J Clin Exp Pathol; 2015; 8(11):15375-80. PubMed ID: 26823897
[TBL] [Abstract][Full Text] [Related]
10. [Changes in clinical and immunological status after post-thymectomized irradiation for invasive thymoma with myasthenia gravis].
Ishida S
Rinsho Shinkeigaku; 1996 May; 36(5):629-32. PubMed ID: 8905980
[TBL] [Abstract][Full Text] [Related]
11. CD4
Kohler S; Keil TOP; Hoffmann S; Swierzy M; Ismail M; Rückert JC; Alexander T; Meisel A
Clin Immunol; 2017 Jun; 179():40-46. PubMed ID: 28286113
[TBL] [Abstract][Full Text] [Related]
12. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
14. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
[TBL] [Abstract][Full Text] [Related]
15. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
Aarli JA; Gilhus NE; Hofstad H
Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic diseases associated with thymoma.
Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
[TBL] [Abstract][Full Text] [Related]
17. Pathomechanisms of paraneoplastic myasthenia gravis.
Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
[TBL] [Abstract][Full Text] [Related]
18. LncRNA XLOC_003810 modulates thymic Th17/Treg balance in myasthenia gravis with thymoma.
Niu L; Jiang J; Yin Y; Hu B
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):989-996. PubMed ID: 32048308
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
[TBL] [Abstract][Full Text] [Related]
20. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
